Growth Metrics

Nektar Therapeutics (NKTR) Amortization - Goodwill (2023)

Nektar Therapeutics (NKTR) has 1 years of Amortization - Goodwill data on record, last reported at $76.5 million in Q1 2023.

  • For Q1 2023, Amortization - Goodwill changed N/A year-over-year to $76.5 million; the TTM value through Dec 2023 reached $76.5 million, changed N/A, while the annual FY2023 figure was $76.5 million, N/A changed from the prior year.
  • Amortization - Goodwill reached $76.5 million in Q1 2023 per NKTR's latest filing.
  • Across five years, Amortization - Goodwill topped out at $76.5 million in Q1 2023 and bottomed at $76.5 million in Q1 2023.